American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Analysts Set Expectations for ADC Therapeutics SA’s Q1 2024 Earnings (NYSE:ADCT)

Analysts Set Expectations for ADC Therapeutics SA’s Q1 2024 Earnings (NYSE:ADCT)

ADC Therapeutics SA (NYSE:ADCT – Free Report) – Equities researchers at HC Wainwright cut their Q1 2024 earnings per share (EPS) estimates for ADC Therapeutics in a report issued on Monday, April 15th. HC Wainwright... More of this article »
Image about Q1 2024 Earnings Forecast for Antero Midstream Co. Issued By Zacks Research (NYSE:AM)

Q1 2024 Earnings Forecast for Antero Midstream Co. Issued By Zacks Research (NYSE:AM)

Antero Midstream Co. (NYSE:AM – Free Report) – Analysts at Zacks Research increased their Q1 2024 earnings per share (EPS) estimates for Antero Midstream in a research note issued on Tuesday, April 16th. Zacks Research... More of this article »
Image about Q1 2024 EPS Estimates for Amgen Inc. (NASDAQ:AMGN) Cut by Analyst

Q1 2024 EPS Estimates for Amgen Inc. (NASDAQ:AMGN) Cut by Analyst

Amgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at William Blair reduced their Q1 2024 earnings per share estimates for shares of Amgen in a note issued to investors on Wednesday, April 17th. William Blair... More of this article »
Image about Capital One Financial Comments on Amphastar Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:AMPH)

Capital One Financial Comments on Amphastar Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:AMPH)

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) – Research analysts at Capital One Financial issued their Q1 2024 earnings per share estimates for shares of Amphastar Pharmaceuticals in a report released... More of this article »
Image about Q1 2024 Earnings Estimate for BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Issued By HC Wainwright

Q1 2024 Earnings Estimate for BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Issued By HC Wainwright

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Free Report) – Equities researchers at HC Wainwright increased their Q1 2024 earnings estimates for BioXcel Therapeutics in a research report issued to clients and investors... More of this article »
Image about Leerink Partnrs Weighs in on AnaptysBio, Inc.’s Q1 2024 Earnings (NASDAQ:ANAB)

Leerink Partnrs Weighs in on AnaptysBio, Inc.’s Q1 2024 Earnings (NASDAQ:ANAB)

AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for AnaptysBio in a report issued on Tuesday, April 16th. Leerink Partnrs analyst... More of this article »
Image about Q1 2024 EPS Estimates for Peabody Energy Co. Cut by Analyst (NYSE:BTU)

Q1 2024 EPS Estimates for Peabody Energy Co. Cut by Analyst (NYSE:BTU)

Peabody Energy Co. (NYSE:BTU – Free Report) – Equities researchers at B. Riley dropped their Q1 2024 EPS estimates for shares of Peabody Energy in a note issued to investors on Monday, April 15th. B. Riley analyst L.... More of this article »
Image about Q1 2024 EPS Estimates for Caterpillar Inc. (NYSE:CAT) Boosted by Zacks Research

Q1 2024 EPS Estimates for Caterpillar Inc. (NYSE:CAT) Boosted by Zacks Research

Caterpillar Inc. (NYSE:CAT – Free Report) – Equities research analysts at Zacks Research boosted their Q1 2024 earnings per share (EPS) estimates for shares of Caterpillar in a note issued to investors on Wednesday,... More of this article »
Image about Q1 2024 EPS Estimates for Aris Mining Co. (NYSE:ARMN) Lowered by Cormark

Q1 2024 EPS Estimates for Aris Mining Co. (NYSE:ARMN) Lowered by Cormark

Aris Mining Co. (NYSE:ARMN – Free Report) – Investment analysts at Cormark dropped their Q1 2024 earnings per share estimates for shares of Aris Mining in a research report issued to clients and investors on Wednesday,... More of this article »
Image about CONSOL Energy Inc. (NYSE:CEIX) to Post Q1 2024 Earnings of $2.19 Per Share, B. Riley Forecasts

CONSOL Energy Inc. (NYSE:CEIX) to Post Q1 2024 Earnings of $2.19 Per Share, B. Riley Forecasts

CONSOL Energy Inc. (NYSE:CEIX – Free Report) – Stock analysts at B. Riley upped their Q1 2024 EPS estimates for shares of CONSOL Energy in a research note issued to investors on Monday, April 15th. B. Riley analyst... More of this article »
Image about WidePoint (NYSEAMERICAN:WYY) Coverage Initiated at StockNews.com

WidePoint (NYSEAMERICAN:WYY) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of WidePoint (NYSEAMERICAN:WYY – Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a “sell” rating on the technology... More of this article »
Image about Group 1 Automotive (NYSE:GPI) Lifted to “Buy” at Guggenheim

Group 1 Automotive (NYSE:GPI) Lifted to “Buy” at Guggenheim

Group 1 Automotive (NYSE:GPI – Get Free Report) was upgraded by Guggenheim from a “neutral” rating to a “buy” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. The firm... More of this article »
Image about YPF Sociedad Anónima (NYSE:YPF) Downgraded to “Neutral” at Citigroup

YPF Sociedad Anónima (NYSE:YPF) Downgraded to “Neutral” at Citigroup

YPF Sociedad Anónima (NYSE:YPF – Get Free Report) was downgraded by analysts at Citigroup from a “buy” rating to a “neutral” rating in a research note issued on Wednesday, MarketBeat reports. They presently... More of this article »
Image about GE Vernova (NYSE:GEV) Coverage Initiated by Analysts at Raymond James

GE Vernova (NYSE:GEV) Coverage Initiated by Analysts at Raymond James

Equities researchers at Raymond James initiated coverage on shares of GE Vernova (NYSE:GEV – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The firm set an “outperform” rating and... More of this article »
Image about DZ Bank Initiates Coverage on First Solar (NASDAQ:FSLR)

DZ Bank Initiates Coverage on First Solar (NASDAQ:FSLR)

Equities research analysts at DZ Bank assumed coverage on shares of First Solar (NASDAQ:FSLR – Get Free Report) in a report issued on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $205.00 price... More of this article »